undefined
Posts
undefined
Followers
User since undefined NaN
#VisualAbstract: Berzosertib Plus Topotecan vs Topotecan Alone in Relapsed Small Cell Lung Cancer
By Alisha Yi,
2023-11-171. The progression-free survival in berzosertib with topotecan vs topotecan alone was not statistically significant, but the overall survival was significant. 2. Grade ≥3 treatment-related adverse events were similar between both groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Genomic instability plays a crucial role in the development of...